An 18-month-old in London, England, is one of the youngest children to receive gene therapy to treat hearing loss caused by a mutation in the OTOF gene. This gene produces a protein called Otoferlin that allows for communication between cells of the cochlea and the brain.

The recipient received an infusion of a functional copy of the OTOF in her ear. The procedure was completed in just 16 minutes. Reportedly, it only took a few weeks for the child to begin to hear and respond to sounds without the help of her cochlear implant.

Read the full article

References

Afzali K. (2024) Toddler born deaf can hear after gene therapy trial breakthrough her parents call “mind-blowing.”CBS News(accessed May 13, 2024).

Share this

Related Posts

Americans Do Not Understand the Importance of Hearing Health

Sleep in U.S. Adults

A New Era in Hearing Care: FDA Approves OTOF Gene Therapy

Recent Posts

Woman with audio waves around her ear on blue background, closeup - Americans Do Not Understand the Importance of Hearing Health

Americans Do Not Understand the Importance of Hearing Health

A new report finds that most Americans are not aware of the impact hearing health can have on their overall health.  Listen To This is a…

Read More
The Centers for Medicare and Medicaid Services (CMS) webpage. CMS is a federal agency within the United States Department of Health and Human Services HHS.

Medicaid Work Requirements Rule Could Affect Access to Hearing Healthcare

The Centers for Medicare and Medicaid Services (CMS) recently issued an Interim Final Rule implementing Medicaid work requirements for certain adult beneficiaries beginning in 2027….

Read More
gray pillow and natural linen bed sheet - Sleep in U.S. Adults

Sleep in U.S. Adults

Previously, we reported on sleep routines and tiredness in children. You may now be wondering how well adults sleep. If so, a recent report by…

Read More